Rigel Pharmaceuticals Inc (RIGL) stock
RIGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30
$42.53−0.39 (-0.91%)
Close on Nov 18, 2026Market cap $794.46MP/E 2.7Yield –
Rigel Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Rigel Pharmaceuticals's pe ratio was 2.8× on Nov 11, 2026, against 8.2× a year earlier. Over the last 3 years it ranged from 1.4× to 131.5×, with a median of 9.9×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.8× | −4.2 |
| 2025 | Dec 31, 2025 | 6.9× | −73.2 |
| 2024 | Dec 31, 2024 | 80.1× | +66.2 |
| 2012 | Feb 29, 2012 | 13.9× | +2.9 |
| 2011 | Dec 30, 2011 | 11.0× | – |
See a number that looks wrong?